SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Argus sets Moderna price target at $180.00 per share

Argus Research announced a $180.00 per-share price target for Moderna.

MRNA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.